facebook

Ocular surface disease treatment algorithm and management

< 1 min read

Ocular surface disease includes dry eye, blepharitis, and allergic or inflammatory problems. Management follows a stepwise approach that escalates from simple measures to advanced therapies.

First-line strategies

Initial treatment focuses on stabilising tears and lids. Many patients improve significantly with consistent basic care.

  • Preservative-free lubricants used regularly rather than only when sore
  • Lid hygiene and warm compresses for meibomian gland dysfunction
  • Environmental adjustments like reducing airflow and managing screen time
  • Allergy control with antihistamine or mast-cell stabiliser drops if relevant

Second-line and advanced treatments

When symptoms persist, additional targeted therapies are considered. These are tailored to the specific surface problem.

  • Anti-inflammatory drops such as cyclosporine or short steroid courses
  • Punctal plugs or cautery to conserve tears
  • In-office gland treatments, serum drops, or scleral lenses for severe disease
  • Regular review to adjust treatment as the surface improves or flares

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.